BIOMAT Database Logo BIOMAT Database Logo

Production and characterization of antipeptide antibodies against human O6-methylguanine-DNA methyltransferase. 1991

L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710.

Four synthetic peptides from the sequence of human O6-methylguanine-DNA methyltransferase (MGMT), three corresponding to different hydrophilic regions and one corresponding to the sequence containing the alkyl acceptor residue cysteine 145, were used to immunize rabbits. The antibody against Peptide III (residues 171-184) was highly specific, and MGMT protein could be detected on Western blots of soluble protein extracts containing as little as 1 fmol of active MGMT. Antibodies against all of the peptides were able to immunoprecipitate denatured MGMT, while only the antibody against Peptide III was able to react with active enzyme. The antibody against Peptide III did not cross-react with methyltransferase from mice. The use of synthetic peptides has led to the production of a highly sensitive, specific antibody that recognizes native and denatured human MGMT. This antibody should prove useful in studies involving the detection, purification, and characterization of this enzyme.

UI MeSH Term Description Entries
D008780 Methyltransferases A subclass of enzymes of the transferase class that catalyze the transfer of a methyl group from one compound to another. (Dorland, 28th ed) EC 2.1.1. Methyltransferase
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
Polyclonal antibodies against O6-methylguanine-DNA methyltransferase in adapted bacteria.
November 1988, Mutation research,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
O6-Methylguanine-DNA methyltransferase in human cells.
January 1984, Mutation research,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
O6-methylguanine-DNA methyltransferase-defective human cell mutant: O6-methylguanine, DNA strand breaks and cytotoxicity.
October 1988, Carcinogenesis,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
O6-methylguanine-DNA methyltransferase and human cancer chemotherapy.
January 1993, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
O6-methylguanine-DNA methyltransferase and human cancer chemotherapy.
June 1991, Science in China. Series B, Chemistry, life sciences & earth sciences,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
Physicochemical studies of human O6-methylguanine-DNA methyltransferase.
October 1990, European journal of biochemistry,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
O6-methylguanine-DNA methyltransferase protects against nitrosamine-induced hepatocarcinogenesis.
July 1993, Proceedings of the National Academy of Sciences of the United States of America,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
O6-methylguanine-DNA methyltransferase activity in human tumors.
September 1992, Carcinogenesis,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
Inactive O6-methylguanine-DNA methyltransferase in human cells.
November 1992, Nucleic acids research,
L E Ostrowski, and C N Pegram, and M A Von Wronski, and P A Humphrey, and X M He, and S Shiota, and S Mitra, and T P Brent, and D D Bigner
Specific recognition of O6-methylguanine in DNA by active site mutants of human O6-methylguanine-DNA methyltransferase.
May 1997, Biochemistry,
Copied contents to your clipboard!